Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Kindly MD ( (NAKA) ).
On August 26, 2025, Kindly MD, Inc. entered into a Sales Agreement with several financial agents, including TD Securities and Cantor Fitzgerald, to offer and sell up to $5 billion of its common stock through an at-the-market offering. This strategic move allows Kindly MD to raise capital flexibly, potentially strengthening its financial position and market presence, while providing agents with a commission of up to 2% on the sales.
The most recent analyst rating on (NAKA) stock is a Hold with a $10.00 price target. To see the full list of analyst forecasts on Kindly MD stock, see the NAKA Stock Forecast page.
Spark’s Take on NAKA Stock
According to Spark, TipRanks’ AI Analyst, NAKA is a Neutral.
The overall stock score is primarily impacted by the company’s poor financial performance, which is a significant concern. While technical analysis and valuation offer some neutral to negative insights, recent corporate events provide a positive outlook, potentially improving future strategic positioning.
To see Spark’s full report on NAKA stock, click here.
More about Kindly MD
Average Trading Volume: 688,446
Technical Sentiment Signal: Buy
Find detailed analytics on NAKA stock on TipRanks’ Stock Analysis page.